FCGR2B and cancer: Despite its critical roles in regulating humoral immunity,9,10,13 FcγRIIB poses a significant obstacle for mAb-mediated immunotherapy of cancer, due to frequent upregulation in both mouse20–22,30,48 and human45,46,49,85 tumors.